HZO vs TSLA

The company presents a stark contrast between deep value metrics and deteriorating fundamental growth. While the Piotroski F-Score of 5/9 indicates a stable financial baseline, the business is struggling with a -16.50% YoY revenue decline and a -71.4% crash in YoY EPS growth. Valuation is highly attractive on a Price-to-Book (0.71) and Price-to-Sales (0.29) basis, but the negative ROE and poor Quick Ratio (0.30) suggest significant liquidity risks and operational inefficiency. The 'Strong Buy' analyst consensus conflicts with a bearish technical trend (10/100), suggesting a speculative value play rather than a growth investment.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.